Continuation Payment. In partial consideration for the rights granted to YmAbs under this Agreement, YmAbs shall pay to MabVax a one-time, non-refundable payment of six hundred thousand U.S. dollars ($600,000) within five (5) days after the first anniversary of the Effective Date, provided that no notice of termination of this Agreement has been made by YmAbs before such date.
Appears in 2 contracts
Sources: Sublicense Agreement (Y-mAbs Therapeutics, Inc.), Sublicense Agreement (Mabvax Therapeutics Holdings, Inc.)